0001382963-20-000086.txt : 20200506 0001382963-20-000086.hdr.sgml : 20200506 20200506171115 ACCESSION NUMBER: 0001382963-20-000086 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200506 DATE AS OF CHANGE: 20200506 EFFECTIVENESS DATE: 20200506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Transposon Therapeutics, Inc. CENTRAL INDEX KEY: 0001810705 IRS NUMBER: 843996895 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366428 FILM NUMBER: 20853571 BUSINESS ADDRESS: STREET 1: 285 RIVERSIDE AVENUE STREET 2: SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (949) 422-9676 MAIL ADDRESS: STREET 1: 285 RIVERSIDE AVENUE STREET 2: SUITE 250 CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001810705 Transposon Therapeutics, Inc. 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT CONNECTICUT 06880 (949) 422-9676 DELAWARE None None Corporation true 2019 Eckard Weber, M.D. 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Executive Officer Director Lynne Rollins 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Executive Officer Brent Ahrens 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Director John Pacifico 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Director Dennis Podlesak 285 Riverside Avenue Suite 250 Westport CT CONNECTICUT 06880 Director Pharmaceuticals Decline to Disclose 06b false 2020-04-21 false true true true true false 0 6500000 4250000 2250000 false 4 0 0 0 false Transposon Therapeutics, Inc. /s/ Lynne Rollins Lynne Rollins CFO and Treasurer 2020-05-06